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Growth of the so-called ‘omics’
technologies may appear to be simply a
case of giving new, trendy names to
boring, old-fashioned technology. After
all, who would dispute that genomics is
just genetics and molecular biology,
glycomics is the study of glycosylation or
that metabolomics is simply the study of
metabolic pathways? Surely, then,
proteomics is just biochemistry. Indeed,
students are now told that they are
studying proteomics, as there is a
tendency to turn off at the mere mention
of biochemistry. 
Biochemistry and bioinformatics
So, is proteomics simply biochemistry? 
The answer is a resounding no! Proteomics 
is a mixture of traditional biochemistry and
the use of web-based bioinformatics tools. 
It enables us to understand and visualise
protein structure, function, interaction and
expression. This is really the traditional
biochemistry aspect. However, using
bioinformatics, it provides the opportunity 
to predict the biochemical properties,
structure and function of proteins that have
been derived from translation of the cloned
nucleotides or polymerase chain reaction
(PCR) products. Indeed, the output of most
genome projects has been random gene
sequences, the function and identity of
which have been derived using 
bioinformatics tools. 
For example, logging on to the Genome
Japan website (www.genome.ad.jp) and
opening the Basic Local Alignment Search
Tool (BLAST) will permit comparison of an
isolated small segment of DNA or a protein
sequence with every one of the billions of
known sequences lodged in databases 
around the world. What’s more, the results
are available in minutes! Analysis of
homology with other proteins then helps to
identify the protein. 
Go to the Expasy Proteomics Server
(http://us.expasy.org/), type in the name of 
a protein and it is possible to access the
TrEBML data set for that protein. Here, it 
is possible to find links to the protein
sequence, the nucleotide sequences (with
any known variants), its function, subcellular
location, tissue specificity, polymorphisms,
disease associations, similarities to other
proteins, and, for some proteins, a specific
website (eg www.albumin.org). Scrolling
down reveals access to projected two-
dimensional (2D) polyacrylamide gel
electrophoresis (PAGE) analysis, 3D
structures, domain structure, post-
translational modifications, the protein
sequence, all known variants (with
references), and the ability to calculate 
pI and mass. 
Far from straightforward
It is not always straightforward, however.
Some organisms have genes and proteins
that show no significant homology to any
other identified. In such cases it is possible
to ask questions via web-based tools. 
For example, is the sequence likely to be
membrane-bound? Does it have motifs like
any other type of protein? With some
proteins, however, properties and function
will only be known when they are purified
and assayed by traditional technology.
So, what else is available? If you teach, 
the Kyoto Encyclopedia of Genes and
Genomes (KEGG), which is available at
Genome Japan, gives links to the KEGG
protein network, and, in turn links to
metabolic pathways, regulatory pathways,
molecular complexes, network-network
relations, network-environment relations 
and diseases. The metabolic pathway pages
are fascinating and allow comparison of
generic pathways with those in your
organism of choice, highlighting the
differences. 
A visit to the Human Protein Reference
Database (www.hprd.org/) ultimately will
provide information on every known human
protein, protein localisation and tissue-
specific expression. This site is still collating
information, but it is an impressive resource,
nonetheless. Protein microarray databases
are now available at the European
Bioinformatics Institute site
(www.ebi.ac.uk/Databases /microarray.html),
where it is possible to visualise some of the
many microarray datasets available. There




Proteomics and bioinformatics are being 
used extensively by pharmaceutical
companies interested in drug targets and
modelling potential protein–drug interaction.
Microarray technology is proving to be a fast
primary screen for drugs and ligands. 
In vaccinology, potential targets are being
found using a combination of traditional
biochemistry and proteomics. Modelling
studies allow drug and ligand refinements 











Modern dictionaries of science would be incomplete without reference to terms 
that end in the suffix ‘omics’. Genomics, proteomics, metabolomics and associated
bioinformatics tools are set to achieve a kind of biological alchemy, as Pamela
Greenwell and Sanjiv Rughooputh explain in a brief introduction to the subject.
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‘Proteomics is a mixture of traditional
biochemistry and the use of 
web-based bioinformatics tools’
 
Protein microarrays are also finding a place
in the analysis of antibodies in, for example,
the understanding of antibody–antigen
binding, the analysis of antibody variants to
determine and improve specificity, and in
autoimmune disease for the identification of
antigen targets. In microbiology, comparative
genome analysis (www.webact.org/) makes it
possible to visualise potential areas
associated with pathogenicity by comparing
pathogenic and non-pathogenic strains. 
In the hunt for surrogate disease markers
of cancer, a range of traditional biochemical
techniques, such as chromatography and 
2D PAGE, makes it possible to discover, for
example, whether the production of
individual proteins is up- or down-regulated,
or whether or not some proteins are
expressed after mutation.
Time to explore
So, will proteomics replace ‘wet’ science?
The answer must be no, as the databases
referred to above rely on information
produced by the traditional scientific
approach. There are also drawbacks to
predicting structure, pI and mass. 
For example, if a protein is heavily
glycosylated, the real values will not reflect
those obtained for the simple polypeptide
chain. However, proteomics will enhance
conventional science, providing rapid
assessments, screening and new
technologies. Clearly, now is the time to
start exploring! Those wishing to download
links, exercises or ask questions should go 
to www.mydocsonline.com/pub/
greenwp/proteomics. n
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